<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urovest</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник урологии</journal-title><trans-title-group xml:lang="en"><trans-title>Urology Herald</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2308-6424</issn><publisher><publisher-name>Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2308-6424-2019-7-3-59-65</article-id><article-id custom-type="elpub" pub-id-type="custom">urovest-273</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Гиперактивный мочевой пузырь и миофасциальный синдром как маска хронического простатита</article-title><trans-title-group xml:lang="en"><trans-title>Masks of Chronic Prostatitis: Overactive bladder and Myofascial Syndrome. Case study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8062-7775</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кульчавеня</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulchavenya</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кульчавеня Екатерина Валерьевна – доктор медицинских наук, профессор; главный научный сотрудник, руководитель отдела урологии для больных урогенитальным туберкулезом ФГБУ «Новосибирский НИИ туберкулёза» МЗ РФ, профессор кафедры туберкулёза ФПК и ППВ ФГБОУ ВО «Новосибирский государственный медицинский университет» МЗ РФ</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Ekaterina V. Kulchavenya – M.D., Ph.D. (M), D.M.S., Full Professor; Chief Researcher, Head, Dept. of Urology for Patients with Urogenital Tuberculosis, Novosibirsk Research Institute of Tuberculosis; Professor, Dept. of Tuberculosis, Novosibirsk State Medical University</p><p>Novosibirsk</p></bio><email xlink:type="simple">urotub@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4560-1611</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баранчукова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Baranchukova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Баранчукова Анжелика Анатольевна – кандидат медицинских наук, доцент кафедры туберкулеза ФПК и ППВ</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Anzhelika A. Baranchukova – M.D., Ph.D. doct.cand. (M), Associate Professor, Dept. of Tuberculosis</p><p>Novosibirsk</p></bio><email xlink:type="simple">koshka.70@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Новосибирский НИИ туберкулёза» МЗ РФ;&#13;
ФГБОУ ВО «Новосибирский государственный медицинский университет» МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk Research Institute of Tuberculosis;&#13;
Novosibirsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Новосибирский государственный медицинский университет» МЗ РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>18</day><month>09</month><year>2019</year></pub-date><volume>7</volume><issue>3</issue><fpage>59</fpage><lpage>65</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кульчавеня Е.В., Баранчукова А.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Кульчавеня Е.В., Баранчукова А.А.</copyright-holder><copyright-holder xml:lang="en">Kulchavenya E.V., Baranchukova A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.urovest.ru/jour/article/view/273">https://www.urovest.ru/jour/article/view/273</self-uri><abstract><p>Простатит — хроническое заболевание, плохо поддающееся терапии, склонное к частым рецидивам и не имеющее чёткой и однозначной клинической картины, что может приводить к диагностическим ошибкам. Описан случай гиперактивного мочевого пузыря и миофасциального синдрома. Клиническая картина была ошибочно интерпретирована как «хронический простатит». Дифференцированный анализ анкет International Prostate Symptom Score (IPSS) и NIH-CPSI (National Institute of Health Chronic Prostatitis Symptom Index), а также пальпация триггерных точек позволили установить верный диагноз. В соответствии с патогенезом был назначен Троспия хлорид (Спазмекс®) по 15 мг дважды в день, Баклофен (Baclophenum) 10 мг ежедневно, Комбилипен (комплекс витаминов группы В) внутримышечно, Нимесулид (Nimesulide) per os, а также локально — низкоинтенсивная лазерная терапия. Через 14 дней пациент отметил выраженное улучшение, интенсивность боли уменьшилась с 8 баллов до 1, ургентных позывов к мочеиспусканию не отмечено, ноктурия прекратилась. Качество жизни соответственно улучшилось до 1 балла по шкале IPSS; по шкале симптомов хронического простатита NIH-CPSI сумма баллов по доменам III и IV снизилась с 11 до 3. Выраженная положительная динамика состояния пациента подтвердила правильность диагноза и лечения.</p></abstract><trans-abstract xml:lang="en"><p>Prostatitis is a chronic disease that does not respond well to therapy. It is prone to frequent relapses and does not have a clear and unambiguous clinical picture, which can lead to diagnostic failure. A case of overactive bladder and myofascial syndrome described. The clinical picture was interpreted as «chronic prostatitis» erroneously. Differentiated analysis of the International Prostate Symptom Score (IPSS) and NIH-CPSI (National Institute of Health Chronic Prostatitis Symptom Index) questionnaires, as well as palpation of trigger points made it possible to establish the correct diagnosis. The following drugs were prescribed: Trospium chloride (Spasmex® ) 15 mg twice a day, Baclоfen (Baclophenum) 10 mg daily, Combilipen (B vitamins multicomplex) intramuscularly, Nimesulide (Nimesulide) orally, and locally low-intensity laser therapy. The patient noted a marked improvement after 14 days: the pain intensity decreased from 8 points to 1, urination urgency was not noted, nocturia stopped. The quality of life (QoL) accordingly improved to 1 point on the IPSS scale. The total score for domains III and IV decreased from 11 to 3 according to the NIH-CPSI symptom scale of chronic prostatitis. The pronounced positive dynamics of the patient’s state of health has confirmed the accuracy of the diagnosis and treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хронический простатит</kwd><kwd>гиперактивный мочевой пузырь</kwd><kwd>диагностические ошибки</kwd><kwd>троспия хлорид (Спазмекс®)</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic prostatitis</kwd><kwd>overactive bladder</kwd><kwd>diagnostic failure</kwd><kwd>trospium chloride (Spasmex®)</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Almeida F, Santos Silva A, Silva Pinto A, Sarmento A. Chronic prostatitis caused by extended-spectrum β-lactamaseproducing Escherichia coli managed using oral fosfomycinA case report. IDCases. 2019;15:e00493. DOI: 10.1016/j.idcr.2019.e00493</mixed-citation><mixed-citation xml:lang="en">Almeida F, Santos Silva A, Silva Pinto A, Sarmento A. Chronic prostatitis caused by extended-spectrum β-lactamaseproducing Escherichia coli managed using oral fosfomycin-A case report. IDCases. 2019;15:e00493. DOI: 10.1016/j.idcr.2019.e00493</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Maurizi A, De Luca F, Zanghi A, Manzi E, Leonardo C, Guidotti M, Antonaccio FP, Olivieri V, De Dominicis C. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids. Arch Ital Urol Androl. 2019;90(4):260-264. DOI: 10.4081/aiua.2018.4.260</mixed-citation><mixed-citation xml:lang="en">Maurizi A, De Luca F, Zanghi A, Manzi E, Leonardo C, Guidotti M, Antonaccio FP, Olivieri V, De Dominicis C. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids. Arch Ital Urol Androl. 2019;90(4):260-264. DOI: 10.4081/aiua.2018.4.260</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhanel GG, Zhanel MA1, Karlowsky JA. Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multi drug-Resistant Escherichia coli. Can J Infect Dis Med Microbiol. 2018;2018:1404813. DOI: 10.1155/2018/1404813</mixed-citation><mixed-citation xml:lang="en">Zhanel GG, Zhanel MA1, Karlowsky JA. Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli. Can J Infect Dis Med Microbiol. 2018;2018:1404813. DOI: 10.1155/2018/1404813</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
